pharmaceuticals

Medical vaccine in shoulder, vaccination

Why This FDA Approval for Valeant Is Not as Good as First Thought

Valeant Pharmaceuticals International Inc. (NYSE: VRX) received a key U.S. Food and Drug Administration (FDA) approval early on Thursday, but it seems to be a mixed blessing. Initially shares were higher ...
Read Full Story »
tired frustrated unhappy business person

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Merck & Co. (NYSE: MRK) saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease. ...
Read Full Story »
100 dollar bills

Why Evoke Pharma Shares Are Exploding

Evoke Pharma Inc. (NASDAQ: EVOK) saw its shares make a huge gain on Wednesday after the company issued an update that it received from the U.S. Food and Drug Administration ...
Read Full Story »
Woman sitting alone and depressed, sad, miserable

Can Sage Therapeutics Press Even Further With Its Depression Trial?

Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw a handy gain on Monday after the company announced a successful mid-stage trial for the treatment of major depressive disorder (MDD). Specifically the ...
Read Full Story »
U Turn

Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?

Zosano Pharma Corp. (NASDAQ: ZSAN) saw its shares absolutely skyrocket on Monday after the firm gave an update on its late-stage trial for the treatment of migraines. Basically, the lead ...
Read Full Story »
Medicine pills

How Rosy Is the Outlook for Teva Pharmaceutical?

Teva Pharmaceutical International Inc. (NYSE: TEVA) reported fourth-quarter and full-year 2016 results before markets opened Monday. The company reported quarterly adjusted diluted earnings per share (EPS) of $1.38 and revenues ...
Read Full Story »
Pair of dice

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Prescription Drugs, Pills

Wednesday’s Biggest Biopharma Movers

Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss. Although ...
Read Full Story »
Pills and tablets

Is Teva’s CEO Departure Long Overdue?

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) saw its shares tumble on Tuesday after the company announced a changing of the guard for its CEO position. The company reported that Dr. ...
Read Full Story »
Prescription drugs

Why Neos Therapeutics Shares Are Hitting a New Low

Neos Therapeutics Inc. (NASDAQ: NEOS) saw its shares sink to a new 52-week low after the company announced that it had priced its secondary offering of common stock. Neos priced ...
Read Full Story »
blue eye

Why Benitec More Than Doubled

Benitec Biopharma Ltd. (NASDAQ: BNTC) saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for ...
Read Full Story »
Female patient on gurney

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares take a sharp turn down after the company reported top-line results from its most recent pharmacokinetic (PK) study. The results were ultimately ...
Read Full Story »
Medical vaccine in shoulder, vaccination

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Merck & Co. (NYSE: MRK) reported its fourth-quarter financial results before the markets opened on Thursday. The company posted $0.89 in earnings per share (EPS) and $10.12 billion in revenue, ...
Read Full Story »
Female patient on gurney

Why Analysts Are Chasing Momenta Pharmaceuticals Even Higher

Shares of Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) made a huge gain on Tuesday after the company reported a key legal decision in its favor. Essentially, the U.S. District Court for the ...
Read Full Story »
bull and bear

2 Key Analysts Strongly Defend Teva After Copaxone Patent Ruling Loss

When pharmaceutical companies lose patent cases on the blockbuster drugs, it usually means that they are at risk of losing billions of dollars in drug sales. When Teva Pharmaceutical Industries ...
Read Full Story »